PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 3, 20260 citations

Self-Assembly Regulation, Drug Release Behavior, Anti-Multidrug Resistance of Redox-Responsive Gemcitabine-Quinine Nanoassemblies in Glioblastoma Therapy.

View Full Paper
JZJiayi ZuoSQShuhui QuHLHaoping Long

Key Points

  • The aim is to evaluate the effectiveness of redox-responsive gemcitabine-quinine nanoassemblies in overcoming multidrug resistance in glioblastoma treatment.
  • Evaluated drug release behavior and toxicity of GQ-S NPs in U251 cells.
  • Assessed apoptotic effects and P-gp expression suppression in treated cells.
  • Measured intracellular gemcitabine levels to determine accumulation effects.
  • GQ-S NPs reduced P-gp expression and increased intracellular gemcitabine levels significantly.
  • GQ-S NPs showed lower cytotoxicity compared to free gemcitabine and conventional nanoassemblies.
  • The design achieved a substantial improvement in targeted therapy due to its low toxicity and high stability.

Abstract

of 1.560 ± 0.123 μM in U251 cells─7-fold and 2.7-fold lower than that of free Gem and GQ-C NPs, respectively. Mechanistic studies revealed that GQ-S NPs induced apoptosis and markedly suppressed P-gp expression, and promoted intracellular Gem accumulation. In summary, GQ-S NPs integrate the advantages of carrier-free design, low toxicity, high stability, and redox-responsive release, offering a promising strategy for targeted combination therapy in drug-resistant glioblastoma.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zuo et al. (2026) studied this question.

synapsesocial.com/papers/69f6e5ac8071d4f1bdfc64eahttps://doi.org/10.1021/acs.langmuir.5c06575
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1003: Targeted co-delivery of gemcitabine and atRA via a GSH-responsive mutual prodrug enhances cytotoxicity through redox imbalance and Pin1 inhibition2026
  2. 2Repurposing gemcitabine for glioblastoma treatment: The role of drug-conjugates and nanoparticles as drug delivery systems2024 · 2 citations
  3. 3Dual Stimuli-Responsive Gemcitabine-Conjugated Alginate-Chitosan Nanoparticles for Triple-Negative Breast Cancer Therapy: A Smart Approach2025 · 10 citations
  4. 4Sustainable gambogic acid release via pH/Redox Dual-Responsive C60-Modified magnetic mesoporous nanospheres for antitumor therapy2024 · 1 citations
  5. 5NIR Responsive Polymeric Prodrug Micelles ZnPc@P(PEG-CMA-TKGEM) for Combating Gemcitabine Drug Delivery in Anticancer Chemotherapy2025